4//SEC Filing
MERRIMACK PHARMACEUTICALS INC 4
Accession 0001209191-17-040140
CIK 0001274792operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:24 PM ET
Size
5.5 KB
Accession
0001209191-17-040140
Insider Transaction Report
Form 4
Santillana Sergio L.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2017-06-13+450,000→ 450,000 totalExercise: $1.35Exp: 2027-06-12→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]This option vests as to 1/6th of the total number of shares granted on 12/12/17 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 6/12/20.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001274792
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:24 PM ET
- Size
- 5.5 KB